ARCHIVES

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

New ACS Program Honors Mary Lasker

August 31, 1984

NCI’s caBIG to Expand For Clinical Informatics Projects.

January 26, 2007

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

October 3, 2014

Roswell Park Researchers Advocate HPV Vaccination For Boys As Well As Girls

May 29, 2009

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen

December 31, 2004